




Evidence-Based Research Series-Paper 3
Using an Evidence-Based Research approach to place your results into context after the
study is performed to ensure usefulness of the conclusion
Lund, Hans; Juhl, Carsten B; Nørgaard, Birgitte; Draborg, Eva; Henriksen, Marius;
Andreasen, Jane; Christensen, Robin; Nasser, Mona; Ciliska, Donna; Tugwell, Peter; Clarke,
Mike; Blaine, Caroline; Martin, Janet; Ban, Jong-Wook; Brunnhuber, Klara; Robinson, Karen
A; Evidence-Based Research Network
Published in:
Journal of Clinical Epidemiology







Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Lund, H., Juhl, C. B., Nørgaard, B., Draborg, E., Henriksen, M., Andreasen, J., Christensen, R., Nasser, M.,
Ciliska, D., Tugwell, P., Clarke, M., Blaine, C., Martin, J., Ban, J-W., Brunnhuber, K., Robinson, K. A., &
Evidence-Based Research Network (2021). Evidence-Based Research Series-Paper 3: Using an Evidence-
Based Research approach to place your results into context after the study is performed to ensure usefulness of
the conclusion. Journal of Clinical Epidemiology, 129, 167-171. https://doi.org/10.1016/j.jclinepi.2020.07.021
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Journal of Clinical Epidemiology 129 (2021) 167e171EVIDENCE BASED RESEARCH SERIES
Evidence-Based Research Series-Paper 3: Using an Evidence-Based
Research approach to place your results into context after the study is
performed to ensure usefulness of the conclusion
Hans Lunda,*, Carsten B. Juhlb,c, Birgitte Nørgaardd, Eva Draborgd, Marius Henriksene,
Jane Andreasenf,g, Robin Christensenh,i, Mona Nasserj, Donna Ciliskaa,k, Peter Tugwelll,
Mike Clarkem, Caroline Blainen, Janet Martino,p, Jong-Wook Banq, Klara Brunnhuberr,
Karen A. Robinsons, on behalf of the Evidence-Based Research Network
aSection for Evidence-based Practice, Western Norway University of Applied Sciences, Bergen, Norway
bFaculty of Health, Institute of Sport Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
cDepartment of Physiotherapy and Occupational Therapy, University Hospital of Copenhagen, Herlev & Gentofte, Copenhagen, Denmark
dDepartment of Public Health, University of Southern Denmark, Odense, Denmark
eThe Parker Institute, Bispebjerg-Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark
fDepartment of Health, Public Health and Epidemiology Group, Science and Technology, Aalborg University, Alborg, Denmark
gDepartment of Physical and Occupational Therapy, Aalborg University Hospital, Aalborg, Denmark
hMusculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
iDepartment of Clinical Research, Research Unit of Rheumatology, University of Southern Denmark, Odense University Hospital, Denmark
jPlymouth Institute of Health and Care Research, Peninsula Dental School, Plymouth University, Plymouth, England, UK
kSchool of Nursing, McMaster University, Hamilton, Ontario, Canada
lDepartment of Medicine and Institute of Population Health, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
mNorthern Ireland Methodology Hub, Queen’s University Belfast, Belfast, Northern Ireland, UK
nBMJ Knowledge Centre, London, UK
oMEDICI Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada
pDepartments of Anesthesia & Perioperative Medicine and Epidemiology & Biostatistics, Western University, London, Ontario, Canada
qEvidence-Based Health Care Programme, University of Oxford, Oxford, UK
rDigital Content Services, Data Platform Operations, Elsevier, London, UK
sJohns Hopkins Evidence-based Practice Center, Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
Accepted 20 July 2020; Published online 23 September 2020AbstractBackground and Objective: There is considerable actual and potential waste in research. Using evidence-based research (EBR) can ensure
the value of a new study. The aim of this article, the third in a series, is to describe an EBR approach to putting research results into context.
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Key findings
 The conclusion of a new study should not be based
on the results from the new study alone but by a
synthesis of existing evidence and new results.
The interpretation and reporting of results from a
new study should be within the context of what
is already known.
What this adds to what was known?
 This article describes the evidence-based research
approach to making and reporting conclusions.
This approach includes an update of the systematic
review that was used to justify and design the study
and a process to decide if there are implications for
clinical practice or if further research is needed.
What is the implication and what should change
now?
 To ensure valid and valuable studies, researchers
should adopt the evidence-based research approach
to determine and report the implications of the new
study results or practice and for future research by
explicitly considering the existing evidence.1. Introduction
Evidence-Based Research (EBR) is the use of prior
research in a systematic and transparent way to inform a
new study so that it is answering questions that matter in
a valid, efficient, and accessible manner [1]. In the previous
article in our EBR series, we discussed the cumulative na-
ture or science and showed the importance of justifying and
designing new studies based on existing knowledge (see
article #2) [2,3]. In this third article of the series, we focus
on the use of an EBR approach after the completion of a
study and make recommendations on how to interpret and
report the results of a new study in the context of the exist-
ing evidence base. We argue that placing the new study re-
sults in the context of what is already known is a key
requisite to creating a meaningful publication that lets
readers assess the value added by the new study, its internal
and external validity, and any similarities and differences
between available studies to support decision-making in
clinical practice and for future research [4].
The importance of these characteristics of good science
has been clearly stated in the reporting standards for clin-
ical studies. The CONSORT statement, first published in
1996, noted the need to ‘‘State general interpretation of
the data in light of the totality of the available evidence’’
[5]. When updated in 2001, the CONSORT statement
included more detailed recommendations on how to placenew results in the context of previous studies, not only rec-
ommending comparing new results with other published
studies, but that whenever possible, this should be per-
formed by using a systematic review [4]. This recommen-
dation was re-emphasized in 2010: ‘‘Readers will want to
know how the present trial’s results relate to those of other
RCTs. This can best be achieved by including a formal sys-
tematic review in the results or discussion section of the
report’’ [6].1.1. Is there a problem?
A single study can very rarely (if ever) provide a defin-
itive answer to the question investigated. Therefore, placing
the new study in the context of relevant previous research is
key, and metaresearch has shown that the interpretation of
new results is at high risk of being biased if only a subset
of earlier studies is included in the discussion of these
new results [7e9].
However, the results of new studies are rarely interpreted
in the context of existing evidence [10e15]. Clarke et al.
repeated investigations of whether clinical trials, published
between 1997 and 2012 in five high-impact medical jour-
nals (Annals of Internal Medicine, BMJ, JAMA, The Lan-
cet, and the New England Journal of Medicine), interpreted
the new trial results by presenting an updated systematic re-
view [10e14]. In 2009, 13 years after the publication of the
first edition of the CONSORT statement, they concluded
that only one study out of 29 examined contained an up-
dated systematic review integrating the new results [13]
and in subsequent updates found no evidence of progress
in reporting results using systematic reviews from 1997
to 2012.1.2. Suggested solution: the evidence-based research
approach
The best way to place new results in the context of ex-
isting evidence is to include the new results in a systematic
review. In this way, the investigator of the new study avoids
the risk of a biased selection of earlier studies and ensures a
trustworthy synthesis of earlier studies.
Preparing a systematic review from scratch is time inten-
sive and effort intensive [16,17]. Identifying or preparing a
systematic review during the planning phase of the new
study will considerably lessen the required work when aim-
ing to place results in context. Consequently, the suggested
EBR approach described in this third article should be
considered alongside the processes for how to justify the
need for a new study and how to design a new study based
on the totality of earlier similar studies (REF to EBR series
article #2).
The relevant steps for this phase of the EBR approach
are highlighted in Figure 1 and described in more detail
in the next section.
Fig. 1. The evidence-based research approach, here highlighting the approach after completion of the study.
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in the context of the overall evidence
Building on the recommendations from CONSORT and
the evaluation of research reporting [10e14,18], we pro-
pose the following EBR process to place the results from
a new study in the context of prior studies.
Considering the impact of the new study results on the
existing evidence raises similar issues as during the plan-
ning phase of the study when deciding whether to update
a systematic review [19] or use an existing one to justify
and design the study [18]. The relevant process is illustrated
in Figure 1, article 2 in this series, where it is also described
how investigators should identify an updated version of the
existing systematic review (and if that is not available, up-
date the systematic review) and how they should use it to
justify and design their new study (REF til article #2 in this
series). The results of the up-to-date systematic review can
then be used as the context for interpreting and discussing
the new findings [20,21]. If the systematic review used dur-
ing the planning phase of the study contained a meta-
analysis and the necessary data from earlier studies are
available, updating the meta-analysis with the new resultsshould be straightforward. At the completion of the new
study, the researcher should assess the effect on the magni-
tude and precision of the effect when adding the new study
to the pre-existing systematic review and assess whether
and how the new results affect the conclusion and level
of certainty.
Ellis et al. provide an example of adding the results of
the new study to an existing meta-analysis in their investi-
gation of taxane as adjuvant chemotherapy for patients with
early breast cancer [22]. When embarking on the study in
2000, only a few studies had presented initial results, but
by the time they were preparing to report the study results
in 2009, a simple search using the search terms ‘taxane’
and ‘breast cancer’ identified a systematic review in the Co-
chrane Library performed by Ferguson et al. [23], and
another systematic review published shortly after the Co-
chrane review [24]. Ellis et al. were able to update these
meta-analyses by adding the results of their new study.
Thus, when discussing the impact for future clinical prac-
tice and research, the key findings included not just the re-
sults from the new study alone, but a much more
meaningful estimate and conclusion based on the combined
results of all studies examining the same clinical question.
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the results of their study on computerized self-help inter-
vention for adolescents seeking help for depression (abbre-
viated SPARX) but discussed their own results within
context of all the earlier studies [25]. They provided the
context for their findings by comparing these with the re-
sults from earlier similar studies identified in a systematic
review [26]. In addition, as data were sparse on adoles-
cents, they complemented this by discussing another sys-
tematic review that included studies on adults and
showed a similar positive effect to that found in earlier
studies and their own new study with adolescents [27].
This way, the authors were able to draw confident conclu-
sions about the benefit of the self-help intervention tested.
Once the new findings are combined with existing evi-
dence, be it through a meta-analysis or not, the next question
is as follows: Is it possible to draw a definitive conclusion or
is further research needed? If a definitive conclusion can be
drawn, this leads to a second question: Do we have confi-
dence in this conclusion, or in other words, is the evidence
of sufficiently high certainty? This process is very similar
to the one described in article #2 of this series, where we es-
tablished the need to take the ethical dimension and the
grading of the evidence (including the statistics) into consid-
eration when assessing the quality of the evidence (REF to
article #2). Again, if the answer to this question is no, further
research is needed. However, if our confidence in the conclu-
sion is high, no further studies are needed, and a recommen-
dation for or against the use of the intervention in clinical
practice can be made (see Figure 2.).
Finally, authors should formulate implications for clin-
ical practice and suggestions for future research based onFig. 2. The process steps from combining the results from the new
study with existing evidence to the decision whether new research is
needed, or if a recommendation for or against the use of the interven-
tion in clinical practice can be made.the totality of the evidence, highlighting the contribution
of the new study. We recognize that numerous factors must
be considered when evaluating the implications of a new
study for both clinical practice and research but want to
stress the role of the EBR approach as a vital step in this
process.1.4. Discussion
In this final article of our three-part series, we discussed
how to use the EBR approach to reach and present a trust-
worthy and meaningful conclusion when reporting the re-
sults of a new clinical study. If new findings are not
placed in the context of all earlier similar studies, the
conclusion is at high risk of being biased. As a result, inter-
ventions without real effects may be introduced into clin-
ical care or there may be erroneous recommendations that
further studies are needed leading to new redundant studies
and so increased research waste.
The focus for evidence-based clinical decisions needs to
move beyond the point estimate and confidence interval of
the single study to considering the aggregate estimate (and
confidence and prediction intervals) from the accumulated
evidence. If the certainty of the overall evidence is either
unclear or low, more research is needed, and reporting this
fact will help mitigate future risk of unnecessary medical
reversal (premature uptake of therapies into practice)
[28]. With a high certainty of the evidence, clinicians
can use the results for clinical decision-making and re-
searchers will be able to avoid repeating conclusive clinical
research, thus avoiding wasteful redundant studies. With its
focus on the totality of evidence and end users’ perspec-
tive, EBR is directly linked to two of the three key compo-
nents of evidence-based medicine, an objective assessment
of all relevant evidence, combined with patient values and
circumstances, when making decisions for clinical care
[29].
Researchers implementing the EBR approach will
require more explicit guidance about how to interpret and
report study results to ensure that study reports effectively
support clinical decision-making and future research.Acknowledgments
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